TTBD expands entrepreneur-in-residence program

After a one-year launch, Technology Transfer and Business Development is expanding its entrepreneur-in-residence program. The program has recruited two additional entrepreneurs-in-residence to provide support to inventor teams and new companies that form when they license technology intellectual property from OHSU. The current entrepreneurs-in-residence, Richard Rylander and Robert Masterson, have helped inventors by saving them time and resources, performing faculty education and outreach, providing grant support, and executing management oversight and commercialization guidance. The new entrepreneurs-in-residence will join the program to continue identifying technologies with commercial promise and provide OHSU researchers with real-world insights about the commercialization process. The new entrepreneurs-in-residence begin their residency at OHSU on Sept. 14.

Rob Arnold, new OHSU entrepreneur-in-residence

Rob Arnold is a healthcare innovation advisor at the University of Washington and partner at Quad+Aim Partners, advising emerging-growth companies on business strategy, planning, and investment. Prior to UW, Arnold was CEO of Geospiza, Inc., a leader in cloud computing solutions for genetic analysis, which was sold to Perkin Elmer in May of 2011. Before that, he was CEO of Crossport Systems, a leader in internet security solutions, which was sold to Lineo/Metrowerks, a division of Motorola. Arnold also co-founded and was CEO of ST Labs, Inc., an international leader in software quality assurance and testing, which was sold to Lionbridge.


Steve Runnels, new OHSU entrepreneur-in-residence

Steve Runnels has more than twenty-eight years of management experience in the healthcare industry. He has held the position of president and CEO of several startup biopharmaceutical companies in the US and Internationally. He was executive vice president and board member of publicly traded NeoTherapeutics, Inc. and vice president of marketing and business development at Sigma-Aldrich, a Fortune 500 company. Mr. Runnels is also an entrepreneur-in-residence at the University of Washington. Mr. Runnels holds a B.S. in cell biology and certification from the American Society of Clinical Pathology as a specialist in immunohematology. He is an M.B.A. and Ph.D. candidate in management.

To see a video of TTBD’s Lunch & Learn presentation on “How to start a company,” presented by entrepreneurs-in-residence, please click here.

For more information on the entrepreneur-in-residence program or to inquire about startup companies at OHSU, please contact Daphne Emerson at